These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20644590)

  • 21. Reverse dot-blot hybridization as an improved tool for the molecular diagnosis of point mutations in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency.
    Yang YP; Corley N; Garcia-Heras J
    Mol Diagn; 2001 Sep; 6(3):193-9. PubMed ID: 11571713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [From gene to disease: adrenogenital syndrome and the CYP21A2 gene].
    Claahsen-van der Grinten HL; Hoefsloot LH
    Ned Tijdschr Geneeskd; 2007 May; 151(21):1174-7. PubMed ID: 17557757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency.
    L'Allemand D; Tardy V; Grüters A; Schnabel D; Krude H; Morel Y
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4562-7. PubMed ID: 11134109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel semiquantitative polymerase chain reaction/enzyme digestion-based method for detection of large scale deletions/conversions of the CYP21 gene and mutation screening in Turkish families with 21-hydroxylase deficiency.
    Tukel T; Uyguner O; Wei JQ; Yuksel-Apak M; Saka N; Song DX; Kayserili H; Bas F; Gunoz H; Wilson RC; New MI; Wollnik B
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5893-7. PubMed ID: 14671187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia: implications for genetic counseling.
    Speiser PW
    Am J Pharmacogenomics; 2001; 1(2):101-10. PubMed ID: 12174671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations.
    Stikkelbroeck NM; Hoefsloot LH; de Wijs IJ; Otten BJ; Hermus AR; Sistermans EA
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3852-9. PubMed ID: 12915679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of four novel mutations in the CYP21 gene in congenital adrenal hyperplasia in the Chinese.
    Lee HH; Chao HT; Lee YJ; Shu SG; Chao MC; Kuo JM; Chung BC
    Hum Genet; 1998 Sep; 103(3):304-10. PubMed ID: 9799085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia.
    Dolzan V; Sólyom J; Fekete G; Kovács J; Rakosnikova V; Votava F; Lebl J; Pribilincova Z; Baumgartner-Parzer SM; Riedl S; Waldhauser F; Frisch H; Stopar-Obreza M; Krzisnik C; Battelino T
    Eur J Endocrinol; 2005 Jul; 153(1):99-106. PubMed ID: 15994751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divergent phenotype of two siblings human leukocyte antigen identical, affected by nonclassical and classical congenital adrenal hyperplasia caused by 21-hydroxylase deficiency.
    Porzio O; Cunsolo V; Malaponti M; De Nisco E; Acquafredda A; Cavallo L; Andreani M; Giardina E; Testi M; Cappa M; Federici G
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4510-3. PubMed ID: 16912133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorescent PCR and automated fragment analysis in preimplantation genetic diagnosis for 21-hydroxylase deficiency in congenital adrenal hyperplasia.
    Van de Velde H; Sermon K; De Vos A; Lissens W; Joris H; Vandervorst M; Van Steirteghem A; Liebaers I
    Mol Hum Reprod; 1999 Jul; 5(7):691-6. PubMed ID: 10381826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency.
    Concolino P; Minucci A; Mello E; Zuppi C; Capoluongo E
    Clin Chem Lab Med; 2009; 47(7):824-5. PubMed ID: 19499972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of molecular defects causing congenital adrenal hyperplasia by cloning and differential hybridization of polymerase chain reaction-amplified 21-hydroxylase (CYP21) genes.
    Helmberg A; Tabarelli M; Fuchs MA; Keller E; Dobler G; Schnegg I; Knorr D; Albert E; Kofler R
    DNA Cell Biol; 1992 Jun; 11(5):359-68. PubMed ID: 1605859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation-haplotype analysis of steroid 21-hydroxylase (CYP21) deficiency in Finland. Implications for the population history of defective alleles.
    Levo A; Partanen J
    Hum Genet; 1997 Apr; 99(4):488-97. PubMed ID: 9099839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation analysis in patients with congenital adrenal hyperplasia in the Spanish population: identification of putative novel steroid 21-hydroxylase deficiency alleles associated with the classic form of the disease.
    Lobato MN; Ordóñez-Sánchez ML; Tusié-Luna MT; Meseguer A
    Hum Hered; 1999 Jun; 49(3):169-75. PubMed ID: 10364682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours.
    Kjellman M; Holst M; Bäckdahl M; Larsson C; Farnebo LO; Wedell A
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):343-6. PubMed ID: 10435060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular identification of combined homozygous and compound heterozygous mutations in the CYP21 gene in simple virilizing congenital adrenal hyperplasia in Taiwan.
    Wang HH; Lee HH; Wu DA; Lee YJ; Chung BC; Wang TR
    Acta Paediatr Taiwan; 2003; 44(6):339-42. PubMed ID: 14983655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital adrenal hyperplasia. Molecular characterization.
    Ko TM; Kao CH; Ho HN; Tseng LH; Hwa HL; Hsu PM; Chuang SM; Lee TY
    J Reprod Med; 1998 Apr; 43(4):379-86. PubMed ID: 9583072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
    Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional analysis of four CYP21 mutations from spanish patients with congenital adrenal hyperplasia.
    Nunez BS; Lobato MN; White PC; Meseguer A
    Biochem Biophys Res Commun; 1999 Sep; 262(3):635-7. PubMed ID: 10471376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.